Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2008, Vol. 35 Issue (3): 211-214    DOI:
Original Research Previous articles | Next articles
Knowledge and general consideration about Pap test screening among women from Finland and Greece
G. Iatrakis1, S. Zervoudis1, P. Peitsidis1, *(), M.M. Nikolaki1, D. Biba1, E. Sotiropoulou1
1Lito Maternity Hospital & TEI University of Athens (Greece)
Download:  PDF(60KB)  ( 4 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
It seems that lack of regular Pap smear screening is a risk factor for cervical cancer. Since women started having Pap smears the number of deaths from cervical cancer has dropped dramatically. The purpose of this study was to investigate the knowledge of women about the essential and basic parameters related to the Pap test in the general population of two European countries: Finland and Greece. The same percentages (> 50%) of women in Athens and Helsinki had good knowledge of the Pap test. Comparing country populations, greater numbers of Finnish women had a better level of Pap test knowledge. Additionally, older women in Finland were more educated and informed about the usage of Pap testing due to the good health service information in this country.
Key words:  Pap test      Cervical cancer screening      HPV     
Published:  10 September 2008     
*Corresponding Author(s):  P. PEITSIDIS     E-mail:  peitsidi@ath.forthnet.gr

Cite this article: 

G. Iatrakis, S. Zervoudis, P. Peitsidis, M.M. Nikolaki, D. Biba, E. Sotiropoulou. Knowledge and general consideration about Pap test screening among women from Finland and Greece. Clinical and Experimental Obstetrics & Gynecology, 2008, 35(3): 211-214.

URL: 

https://ceog.imrpress.com/EN/     OR     https://ceog.imrpress.com/EN/Y2008/V35/I3/211

[1] G. Sel, A. Barut, Ü. Özmen, A. Y. Akdemir, S. Harma, B. Aynalı, M. Harma, M.İ. Harma. Mode of delivery does not have a relationship with high-risk HPV positivity[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 541-545.
[2] P. Karlı, F. Z. Özen. A benign disease characterized by vulvar itching: vulvar vestibular papillomatosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 969-971.
[3] L. Liu, Y.M. Chen, Q.Y. Zhang, C.Z. Li. Roles of high-risk human papilloma virus (HR-HPV) E6/E7mRNA in triaging HPV16/18 cases[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(5): 740-743.
[4] J. X. Cheng, L. L. Yao, H. Xiang, Y. J. Zhan, P. Zhou, M. Yuan, L. P. Mei, Y. Zhang. Cervical cytology ASCUS patients with HPV detection and clinical value[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(4): 592-596.
[5] S. Diamantopoulou, A. Spathis, A. Chranioti, D. Anninos, M. Stamataki, C. Chrelias, A. Pappas, I. Panayiotides, P. Karakitsos. Liquid based cytology and HPV DNA testing in a Greek population compared to colposcopy and histology[J]. Clinical and Experimental Obstetrics & Gynecology, 2013, 40(1): 131-136.
[6] E. Keletzian, A. Koumousidis, S. Dimopoulos, N.J. Varvayannis, A. Kotelis, K. Dimitroglou, N. Kanellopoulos, M. Katsoulis. Contraceptive consciousness and sexual behavior in three different female age groups in Greece: a retrospective study of the evolution during the last three decades[J]. Clinical and Experimental Obstetrics & Gynecology, 2012, 39(2): 160-167.
[7] T. Hamouda, M.A. Freij, M. Saleh. Management of genital warts in pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2012, 39(2): 242-244.
[8] F. Ferenidou, N. Salakos, N. Vaidakis, G. Paltoglou, K. Bakalianou, G. Papadimitriou, G. Creatsas. The impact of HPV diagnosis on women’s sexual and mental health: preliminary findings[J]. Clinical and Experimental Obstetrics & Gynecology, 2012, 39(1): 79-82.
[9] A. Lukic, S. Iannaccio, M. Di Properzio, E. Carico, A. Camboni, A. Vecchione, M. Moscarini. Microcolposcopy in the diagnostic evaluation of abnormal cervical cytology: when and why to do it[J]. Clinical and Experimental Obstetrics & Gynecology, 2009, 36(1): 26-30.
[10] P. Christopoulos, K. Papadias, K. Panoulis, E. Deligeoroglou. Human papilloma virus in adolescence[J]. Clinical and Experimental Obstetrics & Gynecology, 2008, 35(4): 252-254.
[11] W. M. Krambeck, R. M. Cadidé, E. M. Dalmarco, C. M. M. de Cordova. HPV detection and genotyping as an earlier approach in cervical cancer screening of the female genital tract[J]. Clinical and Experimental Obstetrics & Gynecology, 2008, 35(3): 175-178.
[12] A. Frega, E. Baiocco, S. Pace, A. Palazzo, R. Iacovelli, A. Biamonti, M. Moscarini, P. Stentella. Regression rate of clinical HPV infection of the lower genital tract during pregnancy after laser CO2 surgery[J]. Clinical and Experimental Obstetrics & Gynecology, 2006, 33(2): 93-95.
[13] M. Varras. The problems with different management options of women with minor squamous intraepithelial lesions in Pap tests[J]. Clinical and Experimental Obstetrics & Gynecology, 2004, 31(4): 249-250.
[14] S. Alberico, S. Mazza, E. Grimaldi, C. Volpe, S. Guaschino. Essential mixed type II cryoglobulinemia in a HCV positive pregnant woman: case report[J]. Clinical and Experimental Obstetrics & Gynecology, 1998, 25(4): 129-131.
[15] J. L. Garrido. Human Papilloma Virus - H.P.V. condyloma[J]. Clinical and Experimental Obstetrics & Gynecology, 1996, 23(2): 99-102.
No Suggested Reading articles found!